ASML's Earnings Face Scrutiny as U.S. Bill Threatens Key China Revenue

ASML's Q1 2026 earnings face test from US MATCH Act threatening China DUV sales, while strong EUV demand and a €12B buyback support the stock.

Investors are bracing for ASML Holding NV's first-quarter results, set for release on April 15, as the chip equipment giant navigates a potent mix of strong demand and escalating geopolitical risk. The upcoming report will test the sustainability of a 25% stock rally since January, fueled by share buybacks and analyst optimism, against the backdrop of a new U.S. legislative proposal targeting its business in China.

The bipartisan "MATCH Act," introduced in Congress, represents a significant escalation of export controls. Previous restrictions, enacted by the executive branch under both the Trump and Biden administrations, primarily targeted ASML's most advanced extreme ultraviolet (EUV) lithography systems. The new bill would for the first time also prohibit the sale and servicing of older deep ultraviolet (DUV) machines to key Chinese chipmakers, including SMIC, Hua Hong, Huawei, CXMT, and YMTC.

This move directly threatens a revenue stream that has been a pillar of ASML's growth. China accounted for 33% of the company's total sales in 2025, making it the single largest market. While management already expects that share to normalize to around 20% in 2026, the MATCH Act could drive it lower still. Analyst Ben Barringer of Quilter Cheviot estimates the potential damage at roughly 5% of total revenue, noting that the affected DUV tools contribute 10-15% of sales, with China representing about half of that segment.

Against this regulatory uncertainty, the company's operational performance remains robust. For Q1 2026, ASML has guided for revenue between €8.2 billion and €8.9 billion, with a gross margin of 51% to 53%. This represents a decline from the 54% margin reported a year ago, attributed to product mix and softer service revenue. Beyond the headline figures, investors will scrutinize the order conversion rate. With a record order backlog of €38.8 billion, the market is keen to understand how efficiently ASML can translate these bookings into actual sales.

The company continues to demonstrate strength in its most advanced segments. EUV system revenue grew 39% year-over-year in 2025, and more than half of all new bookings are for EUV tools. Deployment of the next-generation High-NA EUV system, the TWINSCAN EXE:5200B, is progressing: Intel has completed acceptance tests, and SK Hynix has already installed the tool in its DRAM fab. CEO Christophe Fouquet anticipates the start of volume production for this system in 2027 and 2028.

Simultaneously, ASML is actively returning capital to shareholders. The company spent approximately €100 million in late March and early April to repurchase nearly 88,000 of its own shares. This is part of a broader program running through 2028 with a total volume of up to €12 billion. Shareholders will also receive a final dividend of €2.70 per share on April 24, a 17% increase compared to the 2024 payout.

The legislative proposal is still in its early stages, and its final form is uncertain. Analyst Stephane Houri of ODDO BHF notes the draft's future is unclear, including whether it would affect all DUV systems or merely extend existing restrictions to specific immersion tools. ASML has not commented on the draft legislation. However, its origin in Congress, rather than the executive branch, signals a broadening political consensus in Washington on confronting China in the technology sector.

Following the earnings release, ASML will hold its annual general meeting on April 22 in Veldhoven. Key agenda items include the appointment of Marco Pieters as Chief Technology Officer and the reappointment of CFO Roger Dassen for a four-year term. The company's long-term targets remain unchanged, aiming for annual revenue between €44 billion and €60 billion by 2030, with gross margins of 56% to 60%.

The consensus price target among analysts stands near €1,482, implying an upside of about 18% from current levels. Tuesday's report and the subsequent management commentary will provide the first concrete data points of the year to assess whether that optimism is justified amidst growing regulatory headwinds.